approval
saveBREXPIPRAZOLE — FDA approval
community read0 votes
Sponsor: AMNEAL. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 6
- phase 2 initiationShanxi Ruifulai Pharmaceutical Co Ltd — brexpiprazole (Phase II Trial Initiation)Apr 28, 2026 · 157d ago
- approvalBREXPIPRAZOLE — FDA approvalApr 1, 2026 · 184d ago
- approvalBREXPIPRAZOLE — FDA approvalApr 1, 2026 · 184d ago
- approvalBREXPIPRAZOLE — FDA approvalApr 1, 2026 · 184d ago
- approvalBREXPIPRAZOLE — FDA approvalApr 1, 2026 · 184d ago
- approvalBREXPIPRAZOLE — FDA approvalJan 31, 2023 · 1340d ago
same company · ±60 days · 6
- approvalBREXPIPRAZOLE: BREXPIPRAZOLE — FDA approvalApr 1, 2026
- approvalBREXPIPRAZOLE: BREXPIPRAZOLE — FDA approvalApr 1, 2026
- approvalBREXPIPRAZOLE: BREXPIPRAZOLE — FDA approvalApr 1, 2026
- approvalBREXPIPRAZOLE: BREXPIPRAZOLE — FDA approvalApr 1, 2026
- approvalCARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER (NICARDIPINE HYDROCHLORIDE) — FDA approvalMar 27, 2026
- approvalELTROMBOPAG OLAMINE — FDA approvalApr 8, 2026
comments(0)
5-min edit window · permanent after that